Last reviewed · How we verify
CHEMICAL PLEURODESIS WITH POVIDONE-IODINE ALONE — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
CHEMICAL PLEURODESIS WITH POVIDONE-IODINE ALONE (CHEMICAL PLEURODESIS WITH POVIDONE-IODINE ALONE) — University College Hospital, Ibadan.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| CHEMICAL PLEURODESIS WITH POVIDONE-IODINE ALONE TARGET | CHEMICAL PLEURODESIS WITH POVIDONE-IODINE ALONE | University College Hospital, Ibadan | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- CHEMICAL PLEURODESIS WITH POVIDONE-IODINE ALONE CI watch — RSS
- CHEMICAL PLEURODESIS WITH POVIDONE-IODINE ALONE CI watch — Atom
- CHEMICAL PLEURODESIS WITH POVIDONE-IODINE ALONE CI watch — JSON
- CHEMICAL PLEURODESIS WITH POVIDONE-IODINE ALONE alone — RSS
Cite this brief
Drug Landscape (2026). CHEMICAL PLEURODESIS WITH POVIDONE-IODINE ALONE — Competitive Intelligence Brief. https://druglandscape.com/ci/chemical-pleurodesis-with-povidone-iodine-alone. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab